A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

NCT04722146 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Teclistamab
DRUG: Daratumumab
DRUG: Pomalidomide
DRUG: Lenalidomide
DRUG: Bortezomib
DRUG: Nirogacestat

Sponsor

Janssen Research & Development, LLC